Skip to main content
Client Work

Exzell Pharma Inc. announces its sale to Biolab Pharma Ltd.

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Exzell Pharma Inc.

On August 4, 2022, Exzell Pharma Inc. (“Exzell”), a Canadian pharmaceutical business, announced its sale to Biolab Pharma Ltd. (“Biolab”). Biolab is a subsidiary of Biolab Sanus Farmacêutica Ltda., with headquarters in Brazil.

Fasken advised Exzell with a team led by Wojtek Baraniak, and that included Kevin Yip (Tax), Alexis Shamess (Corporate), Armand Benitah and Nathan Haldane (Intellectual Property), Robert Iaccino and Ruby Cammarano (Real Estate).

Jurisdiction

  • Ontario

Team

    Subscribe

    Receive email updates from our team

    Subscribe